|
Viatris
(VTRS)
|
5.8 |
$295M |
|
16M |
18.74 |
|
Invitae Corp Note 2.000% 9/0
|
5.2 |
$264M |
|
163M |
1.61 |
|
Nevro Corp Note 1.750% 6/0 (Principal)
|
4.1 |
$209M |
|
116M |
1.80 |
|
Nuvasive Note 2.250% 3/1
|
4.0 |
$201M |
|
200M |
1.01 |
|
Graybug Vision Com Shs
|
3.0 |
$153M |
|
5.3M |
29.02 |
|
Centene Corporation
(CNC)
|
2.9 |
$146M |
|
2.4M |
60.03 |
|
Aerie Pharmaceuticals Note 1.500%10/0
|
2.7 |
$137M |
|
150M |
0.92 |
|
Acutus Medical
(AFIB)
|
2.5 |
$125M |
|
4.3M |
28.81 |
|
Larimar Therapeutics
(LRMR)
|
2.2 |
$110M |
|
5.1M |
21.41 |
|
Biogen Idec
(BIIB)
|
2.2 |
$110M |
|
448k |
244.86 |
|
Springworks Therapeutics
(SWTX)
|
2.1 |
$105M |
|
1.4M |
72.52 |
|
Apellis Pharmaceuticals Note 3.500% 9/1
|
1.8 |
$93M |
|
55M |
1.69 |
|
Oncorus
|
1.8 |
$92M |
|
2.8M |
32.33 |
|
Alexion Pharmaceuticals (Principal)
|
1.8 |
$91M |
|
579k |
156.24 |
|
Nkarta
(NKTX)
|
1.7 |
$87M |
|
1.4M |
61.47 |
|
Rhythm Pharmaceuticals
(RYTM)
|
1.6 |
$81M |
|
2.7M |
29.73 |
|
Insulet Corp Note 0.375% 9/0
|
1.5 |
$76M |
|
58M |
1.33 |
|
Insmed Note 1.750% 1/1
|
1.4 |
$69M |
|
61M |
1.13 |
|
Adapthealth Corp Com Cl A
(AHCO)
|
1.3 |
$68M |
|
1.8M |
37.56 |
|
Pacira Pharmaceuticals
(PCRX)
|
1.2 |
$63M |
|
1.0M |
59.84 |
|
Mirum Pharmaceuticals
(MIRM)
|
1.2 |
$60M |
|
3.4M |
17.46 |
|
Dfp Healthcare Acquisitns Com Cl A
|
1.2 |
$59M |
|
5.5M |
10.80 |
|
Oak Street Health
|
1.1 |
$58M |
|
951k |
61.16 |
|
Dfp Healthcare Acquisitns Unit 03/31/2025
|
1.1 |
$56M |
|
5.0M |
11.21 |
|
Revolution Medicines
(RVMD)
|
1.1 |
$55M |
|
1.4M |
39.59 |
|
Acceleron Pharma
|
1.1 |
$54M |
|
422k |
127.94 |
|
Deerfield Healthcare Tech Ac Com Cl A
|
1.1 |
$53M |
|
3.4M |
15.60 |
|
Fate Therapeutics (Principal)
(FATE)
|
1.0 |
$51M |
|
564k |
90.93 |
|
Cytokinetics Com New
(CYTK)
|
1.0 |
$51M |
|
2.5M |
20.78 |
|
Deerfield Healthcare Tech Ac Unit 07/16/2025
|
1.0 |
$50M |
|
3.4M |
15.00 |
|
Brookdale Senior Living
(BKD)
|
1.0 |
$49M |
|
11M |
4.43 |
|
Intercept Pharmaceuticals In Note 3.250% 7/0
|
0.9 |
$46M |
|
58M |
0.79 |
|
Blueprint Medicines (Principal)
(BPMC)
|
0.9 |
$46M |
|
405k |
112.15 |
|
Clovis Oncology Note 2.500% 9/1
|
0.9 |
$45M |
|
49M |
0.92 |
|
BioCryst Pharmaceuticals
(BCRX)
|
0.9 |
$44M |
|
5.8M |
7.45 |
|
Constellation Pharmceticls I
|
0.8 |
$42M |
|
1.5M |
28.80 |
|
Puma Biotechnology
(PBYI)
|
0.8 |
$41M |
|
4.0M |
10.26 |
|
Meridian Bioscience
|
0.8 |
$40M |
|
2.2M |
18.69 |
|
BioDelivery Sciences International
|
0.8 |
$40M |
|
9.5M |
4.20 |
|
Axonics Modulation Technolog
(AXNX)
|
0.8 |
$40M |
|
800k |
49.92 |
|
Iveric Bio
|
0.8 |
$40M |
|
5.8M |
6.91 |
|
Reata Pharmaceuticals Cl A
|
0.8 |
$40M |
|
320k |
123.62 |
|
Quidel Corporation
|
0.8 |
$40M |
|
220k |
179.65 |
|
Editas Medicine
(EDIT)
|
0.7 |
$38M |
|
539k |
70.11 |
|
Olema Pharmaceuticals
(OLMA)
|
0.7 |
$34M |
|
696k |
48.08 |
|
Lumos Pharma
|
0.7 |
$33M |
|
936k |
35.71 |
|
Pulmonx Corp
(LUNG)
|
0.6 |
$32M |
|
464k |
69.02 |
|
NuVasive
|
0.6 |
$32M |
|
565k |
56.33 |
|
Xeris Pharmaceuticals Note 5.000% 7/1 (Principal)
|
0.6 |
$32M |
|
18M |
1.76 |
|
Novavax Note 3.750% 2/0
|
0.6 |
$31M |
|
25M |
1.25 |
|
Sotera Health
(SHC)
|
0.6 |
$31M |
|
1.1M |
27.44 |
|
Deciphera Pharmaceuticals
|
0.6 |
$30M |
|
529k |
57.07 |
|
Orchard Therapeutics Ads
|
0.6 |
$30M |
|
6.9M |
4.32 |
|
Kodiak Sciences
(KOD)
|
0.6 |
$30M |
|
202k |
146.91 |
|
Owens & Minor
(OMI)
|
0.6 |
$30M |
|
1.1M |
27.05 |
|
Annexon
(ANNX)
|
0.6 |
$29M |
|
1.2M |
25.03 |
|
Alphatec Hldgs Com New
(ATEC)
|
0.6 |
$29M |
|
2.0M |
14.52 |
|
Shattuck Labs
(STTK)
|
0.6 |
$29M |
|
550k |
52.41 |
|
Protagonist Therapeutics
(PTGX)
|
0.5 |
$28M |
|
1.4M |
20.16 |
|
Accolade
(ACCD)
|
0.5 |
$28M |
|
638k |
43.50 |
|
Generation Bio
|
0.5 |
$27M |
|
961k |
28.35 |
|
Molina Healthcare
(MOH)
|
0.5 |
$27M |
|
125k |
212.68 |
|
Adverum Biotechnologies
|
0.5 |
$26M |
|
2.4M |
10.84 |
|
Black Diamond Therapeutics
(BDTX)
|
0.5 |
$26M |
|
803k |
32.05 |
|
Inozyme Pharma
(INZY)
|
0.5 |
$24M |
|
1.2M |
20.64 |
|
Pacira Biosciences Note 2.375% 4/0
|
0.4 |
$23M |
|
20M |
1.14 |
|
OraSure Technologies
(OSUR)
|
0.4 |
$23M |
|
2.1M |
10.59 |
|
Nevro Corp Note 2.750% 4/0 (Principal)
|
0.4 |
$22M |
|
12M |
1.83 |
|
Montes Archimedes Acquisitio Unit 09/30/2025 (Principal)
|
0.4 |
$21M |
|
2.0M |
10.50 |
|
Certara Ord
(CERT)
|
0.4 |
$20M |
|
600k |
33.72 |
|
American Well Corp Cl A
|
0.4 |
$20M |
|
791k |
25.33 |
|
Praxis Precision Medicines I
|
0.4 |
$19M |
|
350k |
55.02 |
|
Protara Therapeutics Com Stk
(TARA)
|
0.4 |
$19M |
|
783k |
24.21 |
|
Ptc Therapeutics Note 3.000% 8/1 (Principal)
|
0.4 |
$19M |
|
15M |
1.28 |
|
Oxford Immunotec Global Ord Shs
|
0.4 |
$18M |
|
1.0M |
17.46 |
|
Medavail Holdings Ord
|
0.3 |
$17M |
|
1.1M |
15.05 |
|
Aligos Therapeutics
|
0.3 |
$17M |
|
600k |
27.65 |
|
Ardelyx
(ARDX)
|
0.3 |
$17M |
|
2.6M |
6.47 |
|
Vapotherm
|
0.3 |
$16M |
|
605k |
26.86 |
|
Alector
(ALEC)
|
0.3 |
$16M |
|
1.1M |
15.13 |
|
Itamar Med Sponsored Ads
|
0.3 |
$16M |
|
794k |
19.86 |
|
Aerie Pharmaceuticals
|
0.3 |
$16M |
|
1.2M |
13.51 |
|
Select Medical Holdings Corporation
(SEM)
|
0.3 |
$16M |
|
565k |
27.66 |
|
Pacific Biosciences of California
(PACB)
|
0.3 |
$15M |
|
575k |
25.94 |
|
Zimmer Holdings
(ZBH)
|
0.3 |
$15M |
|
95k |
154.09 |
|
Boston Scientific Corporation (Principal)
(BSX)
|
0.3 |
$15M |
|
407k |
35.95 |
|
Codiak Biosciences
|
0.3 |
$15M |
|
450k |
32.30 |
|
Stryker Corporation
(SYK)
|
0.3 |
$15M |
|
59k |
245.03 |
|
BioMarin Pharmaceutical
(BMRN)
|
0.3 |
$14M |
|
163k |
87.69 |
|
Profound Med Corp Com New
(PROF)
|
0.3 |
$14M |
|
695k |
20.56 |
|
Scholar Rock Hldg Corp
(SRRK)
|
0.3 |
$14M |
|
289k |
48.53 |
|
Kinnate Biopharma
|
0.3 |
$14M |
|
345k |
39.78 |
|
Imara
|
0.3 |
$13M |
|
578k |
22.05 |
|
Dyne Therapeutics
(DYN)
|
0.2 |
$12M |
|
570k |
21.00 |
|
Avidity Biosciences Ord
(RNA)
|
0.2 |
$12M |
|
454k |
25.52 |
|
Pmv Pharmaceuticals
(PMVP)
|
0.2 |
$12M |
|
187k |
61.51 |
|
Cogent Biosciences
(COGT)
|
0.2 |
$11M |
|
1.0M |
11.23 |
|
Avrobio Ord
(AVRO)
|
0.2 |
$11M |
|
800k |
13.94 |
|
Eucrates Biomedical Acqu Cor Unit 10/23/2027
|
0.2 |
$11M |
|
1.0M |
10.66 |
|
Sarissa Capital Acquisitn Unit 10/23/2027
|
0.2 |
$11M |
|
1.0M |
10.65 |
|
Medtech Acquisition Corp Unit 12/18/2025
|
0.2 |
$11M |
|
1.0M |
10.50 |
|
Highcape Cap Acquisition Cor Unit 09/30/2027
|
0.2 |
$10M |
|
1.0M |
10.32 |
|
Senior Connect Acquisitn Cor Unit 12/09/2023
|
0.2 |
$10M |
|
1.0M |
10.29 |
|
Turning Point Therapeutics I
|
0.2 |
$10M |
|
84k |
121.85 |
|
Neuronetics
(STIM)
|
0.2 |
$10M |
|
919k |
11.11 |
|
Outset Med
|
0.2 |
$9.9M |
|
175k |
56.84 |
|
Bioatla
(BCAB)
|
0.2 |
$9.5M |
|
280k |
34.01 |
|
Delcath Sys Com New
(DCTH)
|
0.2 |
$9.0M |
|
500k |
17.92 |
|
Turmeric Acquisition Corp Unit 10/08/2025
|
0.2 |
$7.7M |
|
750k |
10.27 |
|
Sientra
|
0.1 |
$7.5M |
|
1.9M |
3.89 |
|
Silk Road Medical Inc Common
|
0.1 |
$7.1M |
|
113k |
62.98 |
|
Taysha Gene Therapies Com Shs
(TSHA)
|
0.1 |
$6.6M |
|
250k |
26.54 |
|
Cerevel Therapeutics Hldng I
(CERE)
|
0.1 |
$6.4M |
|
385k |
16.58 |
|
Panacea Acquisition Corp Unit 99/99/9999
|
0.1 |
$6.4M |
|
500k |
12.76 |
|
Arvinas Ord
(ARVN)
|
0.1 |
$6.4M |
|
75k |
84.93 |
|
4d Molecular Therapeutics In
(FDMT)
|
0.1 |
$6.2M |
|
150k |
41.45 |
|
Intersect Ent
|
0.1 |
$5.8M |
|
256k |
22.90 |
|
Cabaletta Bio
(CABA)
|
0.1 |
$5.8M |
|
464k |
12.48 |
|
Benefitfocus Note 1.250%12/1
|
0.1 |
$5.7M |
|
6.5M |
0.88 |
|
Eargo
|
0.1 |
$5.6M |
|
125k |
44.82 |
|
Consonance Hfw Acquisition C Unit 99/99/9999
|
0.1 |
$5.2M |
|
500k |
10.47 |
|
Longview Acquisition Corp *w Exp 05/27/202
|
0.1 |
$4.8M |
|
733k |
6.59 |
|
908 Devices
(MASS)
|
0.1 |
$4.3M |
|
75k |
56.95 |
|
Metacrine Ord
|
0.0 |
$2.2M |
|
278k |
7.86 |
|
Vericel
(VCEL)
|
0.0 |
$2.0M |
|
65k |
30.89 |
|
Fusion Pharmaceuticals
|
0.0 |
$1.9M |
|
162k |
11.75 |
|
Cerevel Therapeutics Hldng I *w Exp 06/09/202
(CEREW)
|
0.0 |
$942k |
|
167k |
5.65 |
|
Neos Therapeutics
|
0.0 |
$201k |
|
321k |
0.63 |
|
Windtree Therapeutics
|
0.0 |
$103k |
|
20k |
5.11 |